A thought provoking and honest discussion of grief, depression, and the DSM-5 featuring Drs. Jerome Wakefield of NYU, Allen Frances of Duke (emeritus), Gary Greenberg, psychotherapist, Lisa Cosgrove of Harvard, Trish Hill of University of Nebraska-Lincoln, Joanne Cacciatore of Arizona State University, Dana Merkling of MISS Foundation. On a personal note, this comes in the midst of a very painful, traumatic loss of my own. I was unaware this would be aired today, so I dedicate my own participation in this documentary to the memory of my friend "T" and her grieving children.
I would highly recommend this program for consumers and clinicians alike. Our gratitude to Matthew Hill, Gemma Newby, and the BBC for their courage in shedding light on this very important topic.
"The Diagnostic and Statistical Manual of Mental Disorders - or DSM - is a book full of lists of symptoms, strange sounding names, codes and guidelines. It's also a book that changes lives. Its champions say it is simply a system of classification, a diagnostic tool. Its critics claim it is more - it decides what is and isn't a disease and that every time a new version is published an increasing number of people are labelled mentally ill.
And for every diagnosis in the DSM, there is a corresponding medical treatment waiting in the wings.
In May 2013, the American Psychiatric Association will publish the latest edition of their DSM and it is likely to cause tension within the American psychiatric establishment.
But why is this medical-looking manual causing such controversy?
Where some say the previous DSM was responsible for pathologising childhood, critics of the new edition will medicalise grief.
Are the intense feelings most people experience after the death of a loved one misery or melancholia? That is the ongoing debate, the result of which will have an impact on millions of people and our understanding of a fundamental human reaction.
In a post-Prozac world, when normal becomes abnormal, medication generally follows. An estimated 8 to 10 million people lose a loved one every year and something like a third to a half of them suffer depressive symptoms for up to a month afterward. How much does the pharmaceutical industry stand to benefit if an extra 5 million people a year are prescribed anti-depressants?
Matthew Hill investigates the DSM, its decisions over what is and is not a mental illness, and the people behind it."